Ventyx Biosciences, Inc.
VTYX
$0.9398
-$0.0602-6.02%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
4/3/2025
-
MarketBeat
4/1/2025
-
Ticker Report
4/1/2025
-
The Fly
4/1/2025
-
GuruFocus
4/1/2025
-
Globe Newswire
3/31/2025
-
Simply Wall St
3/7/2025
-
TipRanks Financial Blog
3/5/2025
-
TipRanks Financial Blog
3/2/2025
-
TipRanks Financial Blog
3/1/2025
-
TipRanks Financial Blog
3/1/2025
-
TipRanks Financial Blog
2/28/2025
-
MarketBeat
2/28/2025
-
TipRanks Financial Blog
2/28/2025
-
Ticker Report
2/27/2025
-
GuruFocus
2/27/2025
-
GuruFocus
2/27/2025
-
The Fly
2/27/2025
-
Globe Newswire
2/18/2025
-
The Fly
2/18/2025
-
GuruFocus
2/18/2025
-
Globe Newswire
2/18/2025
-
MarketBeat
2/17/2025
-
Ticker Report
2/10/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, February 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
760 593 4832
Address
12790 El Camino Real
San Diego, CA 92130
San Diego, CA 92130
Country
Year Founded
Business Description
Sector
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases. The company’s lead...
more
